Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Современный подход к лечению респираторной аллергии
Современный подход к лечению респираторной аллергии
Курбачева О.М., Польнер С.А., Смирнов Д.С. Современный подход к лечению респираторной аллергии. Consilium Medicum. Болезни органов дыхания (Прил.). 2016; с. 28–35.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В данной статье рассматриваются современные подходы к диагностике и терапии двух наиболее распространенных респираторных аллергических заболеваний – аллергического ринита и бронхиальной астмы, а также их сочетания. Рассмотрены группы препаратов, применяемых в лечении данных патологий, и варианты их применения.
Ключевые слова: бронхиальная астма, аллергический ринит, базисная терапия, ингаляционные глюкокортикостероиды, бронхолитическая терапия, монтелукаст, формотерол, будесонид.
Key words: bronchial asthma, allergic rhinitis, base therapy, ICS, broncholitic therapy, montelucast, formoterol, budesonid.
Ключевые слова: бронхиальная астма, аллергический ринит, базисная терапия, ингаляционные глюкокортикостероиды, бронхолитическая терапия, монтелукаст, формотерол, будесонид.
________________________________________________
Key words: bronchial asthma, allergic rhinitis, base therapy, ICS, broncholitic therapy, montelucast, formoterol, budesonid.
Полный текст
Список литературы
1. Гущин И.С., Ильина Н.И., Польнер С.А. Аллергический ринит. Пособие для врачей. М.: ГНЦ Институт иммунологии, РААКИ, 2002. / Gushchin I.S., Il'ina N.I., Pol'ner S.A. Allergicheskii rinit. Posobie dlia vrachei. M.: GNTs Institut immunologii, RAAKI, 2002. [in Russian]
2. Назарова Е.В., Ильина Н.И. Аллергический ринит: актуальные подходы к диагностике и лечению. Эффективная фармакотерапия. Аллергология и иммунология. 2012; 2: 18–24. / Nazarova E.V., Il'ina N.I. Allergicheskii rinit: aktual'nye podkhody k diagnostike i lecheniiu. Effektivnaia farmakoterapiia. Allergologiia i immunologiia. 2012; 2: 18–24. [in Russian]
3. Аллергический ринит. Клинические рекомендации. Педиатрия. Под ред. А.А.Баранова. М.: ГЭОТАР-Медиа, 2005; с. 1–16. / Allergicheskii rinit. Klinicheskie rekomendatsii. Pediatriia. Pod red. A.A.Baranova. M.: GEOTAR-Media, 2005; s. 1–16. [in Russian]
4. Гаращенко Т.И. Аллергические риниты: проблемы медикаментозного лечения. Consilium Medicum. 2000. Экстравыпуск; с. 12–3. / Garashchenko T.I. Allergicheskie rinity: problemy medikamentoznogo lecheniia. Consilium Medicum. 2000. Ekstravypusk; s. 12–3. [in Russian]
5. Государственный реестр лекарственных средств. М.: МЗ РФ, 2008. / Gosudarstvennyi reestr lekarstvennykh sredstv. M.: MZ RF, 2008. [in Russian]
6. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармакус Принт, 1998. / Gushchin I.S. Allergicheskoe vospalenie i ego farmakologicheskii kontrol'. M.: Farmakus Print, 1998. [in Russian]
7. To T, Stanojevic S, Moores G et al. Global Asthma Prevalence in Adults. BMC Public Health 2012; 12: 204.
8. Архипов В.В. Новые перспективы повышения контроля над бронхиальной астмой. От науки к практике. М.: Атмосфера. Практическая пульмонология. 2014; 1: 2–7. / Arkhipov V.V. Novye perspektivy povysheniia kontrolia nad bronkhial'noi astmoi. Ot nauki k praktike. M.: Atmosfera. Prakticheskaia pul'monologiia. 2014; 1: 2–7. [in Russian]
9. Akdis C, Papadopoulos N. Hihglighting research needs in allergy. EAACI newsletter, 2012, issue 29; p. 7.
10. Koberlein J, Anna CK, Sieber J, Mosges R. Determining factors of patient compliance to treatment in allergic rhinitis. Asian PAC J Allergy Immunol 2013; 31 (2): 148–56.
11. Rabe KF, Vermeire AP, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802.
12. Partridge MR, Myrseth S-E, Busse WW et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.
13. Demoly P, Annunziata K, Gubba E et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21 (123): 66.
14. Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; 6: 87. / Arkhipov V.V., Grigor'eva E.V., Gavrishina E.V. Kontrol' nad bronkhial'noi astmoi v Rossii: rezul'taty mnogotsentrovogo nabliudatel'nogo issledovaniia NIKA. Pul'monologiia. 2011; 6: 87. [in Russian]
15. Исследования ГфК-Русь 2012–2013. http://www.evrika.ru/show/6625/
company_feed / Issledovaniia GfK-Rus 2012–2013. http://www.evrika.ru/show/ 6625/company_feed [in Russian]
16. Milgrom H, Bender B, Ackerson L et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051.
17. Rootmensen GN, Jansen HM, de Haan RJ et al. Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method. J Aerosol Med Pulm Drug Deliv 2010; 23 (5): 323.
18. Humbert M, Holgate S, Boulet L-P et al. Asthma control or severity: that is the question (pages 95–101). Allergy 2007; 62 (2): 95.
19. Donohue JF. Therapeutic Responses in Asthma and COPD: Bronchodilators. Chest 2002; 122: 47.
20. Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu Rev Med 1984; 35: 451–67.
21. Joos GF. Potential usefulness of inhibiting neural mechanisms in asthma. Monaldi Arch Chest Dis 2000; 55 (5): 411–4.
22. Peters SP, Kunselman SJ, Icitovic N еt al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363 (18): 1715–26.
23. Bateman ED, Kornmann O, Schmidt P et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128 (2): 315–22.
24. Adams KS, Lowe DK. Ann Pharmacother 2013; 47 (1): 117.
25. Panning CA, DeBisschop M. Tiotropium: an inhaled long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23 (2): 183–9.
26. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010; 16 (2): 97–105.
2. Nazarova E.V., Il'ina N.I. Allergicheskii rinit: aktual'nye podkhody k diagnostike i lecheniiu. Effektivnaia farmakoterapiia. Allergologiia i immunologiia. 2012; 2: 18–24. [in Russian]
3. Allergicheskii rinit. Klinicheskie rekomendatsii. Pediatriia. Pod red. A.A.Baranova. M.: GEOTAR-Media, 2005; s. 1–16. [in Russian]
4. Garashchenko T.I. Allergicheskie rinity: problemy medikamentoznogo lecheniia. Consilium Medicum. 2000. Ekstravypusk; s. 12–3. [in Russian]
5. Gosudarstvennyi reestr lekarstvennykh sredstv. M.: MZ RF, 2008. [in Russian]
6. Gushchin I.S. Allergicheskoe vospalenie i ego farmakologicheskii kontrol'. M.: Farmakus Print, 1998. [in Russian]
7. To T, Stanojevic S, Moores G et al. Global Asthma Prevalence in Adults. BMC Public Health 2012; 12: 204.
8. Arkhipov V.V. Novye perspektivy povysheniia kontrolia nad bronkhial'noi astmoi. Ot nauki k praktike. M.: Atmosfera. Prakticheskaia pul'monologiia. 2014; 1: 2–7. [in Russian]
9. Akdis C, Papadopoulos N. Hihglighting research needs in allergy. EAACI newsletter, 2012, issue 29; p. 7.
10. Koberlein J, Anna CK, Sieber J, Mosges R. Determining factors of patient compliance to treatment in allergic rhinitis. Asian PAC J Allergy Immunol 2013; 31 (2): 148–56.
11. Rabe KF, Vermeire AP, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802.
12. Partridge MR, Myrseth S-E, Busse WW et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.
13. Demoly P, Annunziata K, Gubba E et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21 (123): 66.
14. Arkhipov V.V., Grigor'eva E.V., Gavrishina E.V. Kontrol' nad bronkhial'noi astmoi v Rossii: rezul'taty mnogotsentrovogo nabliudatel'nogo issledovaniia NIKA. Pul'monologiia. 2011; 6: 87. [in Russian]
15. Issledovaniia GfK-Rus 2012–2013. http://www.evrika.ru/show/ 6625/company_feed [in Russian]
16. Milgrom H, Bender B, Ackerson L et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051.
17. Rootmensen GN, Jansen HM, de Haan RJ et al. Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method. J Aerosol Med Pulm Drug Deliv 2010; 23 (5): 323.
18. Humbert M, Holgate S, Boulet L-P et al. Asthma control or severity: that is the question (pages 95–101). Allergy 2007; 62 (2): 95.
19. Donohue JF. Therapeutic Responses in Asthma and COPD: Bronchodilators. Chest 2002; 122: 47.
20. Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu Rev Med 1984; 35: 451–67.
21. Joos GF. Potential usefulness of inhibiting neural mechanisms in asthma. Monaldi Arch Chest Dis 2000; 55 (5): 411–4.
22. Peters SP, Kunselman SJ, Icitovic N еt al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363 (18): 1715–26.
23. Bateman ED, Kornmann O, Schmidt P et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128 (2): 315–22.
24. Adams KS, Lowe DK. Ann Pharmacother 2013; 47 (1): 117.
25. Panning CA, DeBisschop M. Tiotropium: an inhaled long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23 (2): 183–9.
26. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010; 16 (2): 97–105.
2. Назарова Е.В., Ильина Н.И. Аллергический ринит: актуальные подходы к диагностике и лечению. Эффективная фармакотерапия. Аллергология и иммунология. 2012; 2: 18–24. / Nazarova E.V., Il'ina N.I. Allergicheskii rinit: aktual'nye podkhody k diagnostike i lecheniiu. Effektivnaia farmakoterapiia. Allergologiia i immunologiia. 2012; 2: 18–24. [in Russian]
3. Аллергический ринит. Клинические рекомендации. Педиатрия. Под ред. А.А.Баранова. М.: ГЭОТАР-Медиа, 2005; с. 1–16. / Allergicheskii rinit. Klinicheskie rekomendatsii. Pediatriia. Pod red. A.A.Baranova. M.: GEOTAR-Media, 2005; s. 1–16. [in Russian]
4. Гаращенко Т.И. Аллергические риниты: проблемы медикаментозного лечения. Consilium Medicum. 2000. Экстравыпуск; с. 12–3. / Garashchenko T.I. Allergicheskie rinity: problemy medikamentoznogo lecheniia. Consilium Medicum. 2000. Ekstravypusk; s. 12–3. [in Russian]
5. Государственный реестр лекарственных средств. М.: МЗ РФ, 2008. / Gosudarstvennyi reestr lekarstvennykh sredstv. M.: MZ RF, 2008. [in Russian]
6. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармакус Принт, 1998. / Gushchin I.S. Allergicheskoe vospalenie i ego farmakologicheskii kontrol'. M.: Farmakus Print, 1998. [in Russian]
7. To T, Stanojevic S, Moores G et al. Global Asthma Prevalence in Adults. BMC Public Health 2012; 12: 204.
8. Архипов В.В. Новые перспективы повышения контроля над бронхиальной астмой. От науки к практике. М.: Атмосфера. Практическая пульмонология. 2014; 1: 2–7. / Arkhipov V.V. Novye perspektivy povysheniia kontrolia nad bronkhial'noi astmoi. Ot nauki k praktike. M.: Atmosfera. Prakticheskaia pul'monologiia. 2014; 1: 2–7. [in Russian]
9. Akdis C, Papadopoulos N. Hihglighting research needs in allergy. EAACI newsletter, 2012, issue 29; p. 7.
10. Koberlein J, Anna CK, Sieber J, Mosges R. Determining factors of patient compliance to treatment in allergic rhinitis. Asian PAC J Allergy Immunol 2013; 31 (2): 148–56.
11. Rabe KF, Vermeire AP, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802.
12. Partridge MR, Myrseth S-E, Busse WW et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.
13. Demoly P, Annunziata K, Gubba E et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21 (123): 66.
14. Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология. 2011; 6: 87. / Arkhipov V.V., Grigor'eva E.V., Gavrishina E.V. Kontrol' nad bronkhial'noi astmoi v Rossii: rezul'taty mnogotsentrovogo nabliudatel'nogo issledovaniia NIKA. Pul'monologiia. 2011; 6: 87. [in Russian]
15. Исследования ГфК-Русь 2012–2013. http://www.evrika.ru/show/6625/
company_feed / Issledovaniia GfK-Rus 2012–2013. http://www.evrika.ru/show/ 6625/company_feed [in Russian]
16. Milgrom H, Bender B, Ackerson L et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051.
17. Rootmensen GN, Jansen HM, de Haan RJ et al. Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method. J Aerosol Med Pulm Drug Deliv 2010; 23 (5): 323.
18. Humbert M, Holgate S, Boulet L-P et al. Asthma control or severity: that is the question (pages 95–101). Allergy 2007; 62 (2): 95.
19. Donohue JF. Therapeutic Responses in Asthma and COPD: Bronchodilators. Chest 2002; 122: 47.
20. Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu Rev Med 1984; 35: 451–67.
21. Joos GF. Potential usefulness of inhibiting neural mechanisms in asthma. Monaldi Arch Chest Dis 2000; 55 (5): 411–4.
22. Peters SP, Kunselman SJ, Icitovic N еt al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363 (18): 1715–26.
23. Bateman ED, Kornmann O, Schmidt P et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128 (2): 315–22.
24. Adams KS, Lowe DK. Ann Pharmacother 2013; 47 (1): 117.
25. Panning CA, DeBisschop M. Tiotropium: an inhaled long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23 (2): 183–9.
26. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010; 16 (2): 97–105.
________________________________________________
2. Nazarova E.V., Il'ina N.I. Allergicheskii rinit: aktual'nye podkhody k diagnostike i lecheniiu. Effektivnaia farmakoterapiia. Allergologiia i immunologiia. 2012; 2: 18–24. [in Russian]
3. Allergicheskii rinit. Klinicheskie rekomendatsii. Pediatriia. Pod red. A.A.Baranova. M.: GEOTAR-Media, 2005; s. 1–16. [in Russian]
4. Garashchenko T.I. Allergicheskie rinity: problemy medikamentoznogo lecheniia. Consilium Medicum. 2000. Ekstravypusk; s. 12–3. [in Russian]
5. Gosudarstvennyi reestr lekarstvennykh sredstv. M.: MZ RF, 2008. [in Russian]
6. Gushchin I.S. Allergicheskoe vospalenie i ego farmakologicheskii kontrol'. M.: Farmakus Print, 1998. [in Russian]
7. To T, Stanojevic S, Moores G et al. Global Asthma Prevalence in Adults. BMC Public Health 2012; 12: 204.
8. Arkhipov V.V. Novye perspektivy povysheniia kontrolia nad bronkhial'noi astmoi. Ot nauki k praktike. M.: Atmosfera. Prakticheskaia pul'monologiia. 2014; 1: 2–7. [in Russian]
9. Akdis C, Papadopoulos N. Hihglighting research needs in allergy. EAACI newsletter, 2012, issue 29; p. 7.
10. Koberlein J, Anna CK, Sieber J, Mosges R. Determining factors of patient compliance to treatment in allergic rhinitis. Asian PAC J Allergy Immunol 2013; 31 (2): 148–56.
11. Rabe KF, Vermeire AP, Soriano JB et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802.
12. Partridge MR, Myrseth S-E, Busse WW et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.
13. Demoly P, Annunziata K, Gubba E et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21 (123): 66.
14. Arkhipov V.V., Grigor'eva E.V., Gavrishina E.V. Kontrol' nad bronkhial'noi astmoi v Rossii: rezul'taty mnogotsentrovogo nabliudatel'nogo issledovaniia NIKA. Pul'monologiia. 2011; 6: 87. [in Russian]
15. Issledovaniia GfK-Rus 2012–2013. http://www.evrika.ru/show/ 6625/company_feed [in Russian]
16. Milgrom H, Bender B, Ackerson L et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 1051.
17. Rootmensen GN, Jansen HM, de Haan RJ et al. Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring Method. J Aerosol Med Pulm Drug Deliv 2010; 23 (5): 323.
18. Humbert M, Holgate S, Boulet L-P et al. Asthma control or severity: that is the question (pages 95–101). Allergy 2007; 62 (2): 95.
19. Donohue JF. Therapeutic Responses in Asthma and COPD: Bronchodilators. Chest 2002; 122: 47.
20. Nadel JA, Barnes PJ. Autonomic regulation of the airways. Annu Rev Med 1984; 35: 451–67.
21. Joos GF. Potential usefulness of inhibiting neural mechanisms in asthma. Monaldi Arch Chest Dis 2000; 55 (5): 411–4.
22. Peters SP, Kunselman SJ, Icitovic N еt al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363 (18): 1715–26.
23. Bateman ED, Kornmann O, Schmidt P et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128 (2): 315–22.
24. Adams KS, Lowe DK. Ann Pharmacother 2013; 47 (1): 117.
25. Panning CA, DeBisschop M. Tiotropium: an inhaled long-acting anticholinergic drug for chronic obstructive pulmonary disease. Pharmacotherapy 2003; 23 (2): 183–9.
26. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010; 16 (2): 97–105.
Авторы
О.М.Курбачева*, С.А.Польнер, Д.С.Смирнов
ФГБУ ГНЦ Институт иммунологии ФМБА России. 115478, Россия, Москва, Каширское ш., д. 24, корп. 2
*kurbacheva@gmail.com
Institute of Immunology of FMBA of Russia. 115478, Russian Federation, Moscow, Kashirskoie sh., d. 24, str. 2
*kurbacheva@gmail.com
ФГБУ ГНЦ Институт иммунологии ФМБА России. 115478, Россия, Москва, Каширское ш., д. 24, корп. 2
*kurbacheva@gmail.com
________________________________________________
Institute of Immunology of FMBA of Russia. 115478, Russian Federation, Moscow, Kashirskoie sh., d. 24, str. 2
*kurbacheva@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.